Publications

• Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial.Grilo CM, Ivezaj V, Tek C, Yurkow S, Wiedemann AA, Gueorguieva R. Am J Psychiatry. 2024 Dec 11; 2024 Dec 11. PMID: 39659158.
• Brief Cognitive Behavioral Therapy for Suicidal Inpatients: A Randomized Clinical Trial.Diefenbach GJ, Lord KA, Stubbing J, Rudd MD, Levy HC, Worden B, Sain KS, Bimstein JG, Rice TB, Everhardt K, Gueorguieva R, Tolin DF. JAMA Psychiatry. 2024 Dec 1. PMID: 39259550.
• Smartband-based smoking detection and real-time brief mindfulness intervention: findings from a feasibility clinical trial.Horvath M, Pittman B, O'Malley SS, Grutman A, Khan N, Gueorguieva R, Brewer JA, Garrison KA. Ann Med. 2024 Dec; 2024 Jun 1. PMID: 38823419.
• Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data.Lochmann van Bennekom MWH, IntHout J, Gijsman HJ, Akdede BBK, Yağcıoğlu AEA, Barnes TRE, Galling B, Gueorguieva R, Kasper S, Kreinin A, Nielsen J, Nielsen RE, Remington G, Repo-Tiihonen E, Schmidt-Kraepelin C, Shafti SS, Xiao L, Correll CU, Verkes RJ. Schizophr Res. 2024 Oct; 2024 Aug 13. PMID: 39142215.
• Lisdexamfetamine maintenance treatment for binge-eating disorder following successful treatments: randomized double-blind placebo-controlled trial.Grilo CM, Ivezaj V, Yurkow S, Tek C, Wiedemann AA, Gueorguieva R. Psychol Med. 2024 Sep 11; 2024 Sep 11. PMID: 39258475.
• Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humans.Parida S, MacLean RR, Gueorguieva R, Sofuoglu M. Psychopharmacology (Berl). 2024 Sep; 2024 Jul 6. PMID: 38970644.
• Behavioral Precursors of Nicotine Product Use Trajectories Among Youth.Buta E, Gueorguieva R, Simon P, Garrison KA. Am J Prev Med. 2024 Sep; 2024 May 21. PMID: 38782105.
• Lower Dorsal Putamen D2/3 Receptor Availability and Amphetamine-Induced Dopamine Release are Related to Poorer Cognitive Function in Recently Abstinent People Who Smoke and Healthy Controls.Cheung F, Calakos KC, Gueorguieva R, Hillmer AT, Cosgrove KP, Zakiniaeiz Y. Nicotine Tob Res. 2024 Jul 22. PMID: 38367211.
• Socioecological factors associated with multiple nicotine product use among U.S. youth: Findings from the population assessment of tobacco and health (PATH) study 2013-2018.Simon P, Stefanovics E, Ying S, Gueorguieva R, Krishnan-Sarin S, Buta E. Prev Med. 2024 Jun; 2024 Apr 13. PMID: 38615947.
• Overvaluation of shape/weight at posttreatment predicts relapse at 12-month follow-up after successful behaviorally-based treatment of binge-eating disorder.Grilo CM, Ivezaj V, Gueorguieva R. Int J Eat Disord. 2024 May; 2024 Feb 6. PMID: 38321617.
• An International, Multidisciplinary Consensus Set of Patient-Centered Outcome Measures for Substance-Related and Addictive Disorders.Black N, Chung S, Tisdale C, Fialho LS, Aramrattana A, Assanangkornchai S, Blaszczynski A, Bowden-Jones H, van den Brink W, Brown A, Brown QL, Cottler LB, Elsasser M, Ferri M, Florence M, Gueorguieva R, Hampton R, Hudson S, Kelly PJ, Lintzeris N, Murphy L, Nadkarni A, Neale J, Rosen D, Rumpf HJ, Rush B, Segal G, Shorter GW, Torrens M, Wait C, Young K, Farrell M. J Clin Med. 2024 Apr 8; 2024 Apr 8. PMID: 38610919.
• The role of neurosteroids in posttraumatic stress disorder and alcohol use disorder: A review of 10 years of clinical literature and treatment implications.Peltier MR, Verplaetse TL, Altemus M, Zakiniaeiz Y, Ralevski EA, Mineur YS, Gueorguieva R, Picciotto MR, Cosgrove KP, Petrakis I, McKee SA. Front Neuroendocrinol. 2024 Apr; 2024 Jan 4. PMID: 38184208.
• Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening.Cartmel B, Fucito LM, Bold KW, Neveu S, Li F, Rojewski AM, Gueorguieva R, O'Malley SS, Herbst RS, Toll BA. J Thorac Oncol. 2024 Apr; 2023 Nov 15. PMID: 37977486.
• A randomized controlled trial of potential tobacco policies prohibiting menthol flavor in cigarettes and e-cigarettes: a study protocol.Bold KW, Sharma A, Haeny A, Gueorguieva R, Buta E, Baldassarri S, Lempert L, Krishnan-Sarin S, O'Malley S. BMC Psychiatry. 2024 Mar 12; 2024 Mar 12. PMID: 38475757.
• Associations Between Childhood Trauma and Tobacco Use Outcomes in Adults after Overnight Abstinence.Palmisano AN, Schwartz EKC, Gueorguieva R, Sofuoglu M. Nicotine Tob Res. 2024 Feb 22. PMID: 37565294.
• Illusory generalizability of clinical prediction models.Chekroud AM, Hawrilenko M, Loho H, Bondar J, Gueorguieva R, Hasan A, Kambeitz J, Corlett PR, Koutsouleris N, Krumholz HM, Krystal JH, Paulus M. Science. 2024 Jan 12; 2024 Jan 11. PMID: 38207039.
• Evidence of subgroup differences in meta-analyses evaluating medications for alcohol use disorder: An umbrella review.Wallach JD, Glick L, Gueorguieva R, O'Malley SS. Alcohol Clin Exp Res (Hoboken). 2024 Jan; 2023 Dec 15. PMID: 38102794.
• Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial.Grilo CM, Lydecker JA, Gueorguieva R. Psychol Med. 2023 Dec; 2023 Jun 27. PMID: 37366017.
• Relationship Between Pain and LGBT Status Among Veterans in Care in a Retrospective Cross-Sectional Cohort.Gordon KS, Buta E, Pratt-Chapman ML, Brandt CA, Gueorguieva R, Warren AR, Workman TE, Zeng-Treitler Q, Goulet JL. J Pain Res. 2023; 2023 Nov 30. PMID: 38054108.
• Randomized trial of mindfulness- and reappraisal-based regulation of craving training among daily cigarette smokers.Roos CR, Harp NR, Vafaie N, Gueorguieva R, Frankforter T, Carroll KM, Kober H. Psychol Addict Behav. 2023 Nov; 2023 Aug 3. PMID: 37535555.
• Including the term 'tobacco-free nicotine' in the nicotine addiction warning label mandated by the US Food and Drug Administration alters risk perceptions and use intentions.Morean ME, Gueorguieva R, O'Malley S, Krishnan-Sarin S. Tob Control. 2023 Oct 28; 2023 Oct 28. PMID: 37898544.
• Discriminating cocaine use from other sympathomimetics using wearable electrocardiographic (ECG) sensors.Angarita GA, Pittman B, Nararajan A, Mayerson TF, Parate A, Marlin B, Gueorguieva RR, Potenza MN, Ganesan D, Malison RT. Drug Alcohol Depend. 2023 Sep 1; 2023 Jul 14. PMID: 37523916.
• Developing Researchers with Expertise in Sex as a Biological Variable through SCORE Career Enhancement Core Center Programs.Zakiniaeiz Y, Peltier MR, Mineur YS, Gueorguieva R, Picciotto MR, Petrakis I, Cosgrove KP, McKee SA. J Womens Health (Larchmt). 2023 Aug. PMID: 37585509.
• Cognitive-behavioral therapy for binge-eating disorder for non-responders to initial acute treatments: Randomized controlled trial.Grilo CM, Lydecker JA, Gueorguieva R. Int J Eat Disord. 2023 Aug; 2023 May 5. PMID: 37144325.
• Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.Yonkers KA, Altemus M, Gilstad-Hayden K, Kornstein SG, Gueorguieva R. J Clin Psychopharmacol. 2023 Jul-Aug 01; 2023 May 22. PMID: 37212651.
• Gambling participation among Connecticut adolescents from 2007 to 2019: Potential risk and protective factors.Stefanovics EA, Gueorguieva R, Zhai ZW, Potenza MN. J Behav Addict. 2023 Jun 29; 2023 Jun 19. PMID: 37335777.
• Sex steroid hormone levels associated with dopamine D(2/3) receptor availability in people who smoke cigarettes.Zakiniaeiz Y, Gueorguieva R, Peltier MR, Verplaetse TL, Roberts W, McKee SA, Cosgrove KP. Front Behav Neurosci. 2023; 2023 Jun 9. PMID: 37358969.
• Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia.Surti TS, Ranganathan M, Johannesen JK, Gueorguieva R, Deaso E, Kenney JG, Krystal JH, D'Souza DC. Schizophr Res. 2023 Jun; 2023 May 2. PMID: 37141764.
• A Network Analysis of Cigarette Craving.Aslan M, Sala M, Gueorguieva R, Garrison KA. Nicotine Tob Res. 2023 May 22. PMID: 36757093.
• Examining racial differences in smoking outcomes among smokers enrolled in an intravenous nicotine infusion study.Schwartz EKC, Palmisano AN, Gueorguieva R, DeVito EE, Sofuoglu M. Addict Behav. 2023 May; 2023 Jan 9. PMID: 36640662.
• Change in impulsivity is prospectively associated with treatment outcomes for binge-eating disorder.Boswell RG, Gueorguieva R, Grilo CM. Psychol Med. 2023 May; 2021 Nov 23. PMID: 34812713.
• Models for Zero-Inflated and Overdispersed Correlated Count Data: An Application to Cigarette Use.Pittman B, Buta E, Garrison K, Gueorguieva R. Nicotine Tob Res. 2023 Apr 6. PMID: 36318799.
• Lower Dopamine D2/3 Receptor Availability is Associated With Worse Verbal Learning and Memory in People Who Smoke Cigarettes.Zakiniaeiz Y, Gueorguieva R, Peltier MR, Roberts W, Verplaetse TL, Burke C, Morris ED, McKee SA, Cosgrove KP. Nicotine Tob Res. 2023 Apr 6. PMID: 36107715.
• A Network Investigation of Core Mindfulness Processes.Sala M, Aslan M, Gueorguieva R, Schupak M, Garrison KA. Mindfulness (N Y). 2023 Apr; 2023 Apr 13. PMID: 38854675.
• The first nicotine product tried is associated with current multiple nicotine product use and nicotine dependence among a nationally representative sample of U.S. youths.Simon P, Buta E, Jackson A, Camenga DR, Kong G, Morean ME, Bold KW, Davis DR, Krishnan-Sarin S, Gueorguieva R. Prev Med. 2023 Apr; 2023 Jan 30. PMID: 36731754.
• Ketamine Effects on Energy Metabolism, Functional Connectivity and Working Memory in Healthy Humans.Driesen NR, Herman P, Rowland MA, Thompson G, Qiu M, He G, Fineberg S, Barron DS, Helgeson L, Lacadie C, Chow R, Gueorguieva R, Straun TC, Krystal JH, Hyder F. bioRxiv. 2023 Feb 22; 2023 Feb 22. PMID: 36865249.
• Threshold for the pleasurable effects of nicotine are lower than its reinforcing effects during self-administration.MacLean RR, Eid T, Parida S, Gueorguieva R, DeVito EE, Sofuoglu M. Exp Clin Psychopharmacol. 2023 Feb; 2022 Mar 7. PMID: 35254839.
• Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial.Grilo CM, Lydecker JA, Fineberg SK, Moreno JO, Ivezaj V, Gueorguieva R. Am J Psychiatry. 2022 Dec 1; 2022 Oct 26. PMID: 36285406.
• Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain.Buta E, Gordon KS, Gueorguieva R, Becker WC, Heapy A, Bathulapalli H, Zeng Q, Redd D, Brandt C, Goulet J. Pharmacoepidemiol Drug Saf. 2022 Dec; 2022 Sep 27. PMID: 35996825.
• 24-Month follow-up of randomized controlled trial of guided-self-help for loss-of-control eating after bariatric surgery.Grilo CM, Ivezaj V, Duffy AJ, Gueorguieva R. Int J Eat Disord. 2022 Nov; 2022 Aug 24. PMID: 36054766.
• Development of pulsed intravenous nicotine infusions as a model for inhaled nicotine in humans.De Aquino JP, DeVito EE, Xie C, Meyerovich J, Parida S, Gueorguieva R, Sofuoglu M. Psychopharmacology (Berl). 2022 Sep; 2022 May 13. PMID: 35554617.
• Predictors of abstinence, no heavy drinking days, and a 2-level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study.Wallach JD, Gueorguieva R, Phan H, Witkiewitz K, Wu R, O'Malley SS. Alcohol Clin Exp Res. 2022 Jul; 2022 Jun 13. PMID: 35616436.
• Examining the potential role of e-cigarettes to reduce health disparities associated with menthol cigarette use: Characterizing e-cigarette use, flavors, and reasons for use among US adults smoking menthol cigarettes.Bold KW, Buta E, Simon P, Gueorguieva R, Jackson A, Suttiratana SC, Krishnan-Sarin S, O'Malley SS. Drug Alcohol Depend. 2022 Jul 1; 2022 Apr 27. PMID: 35594642.
• Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, Southwick SM, Petrakis IL, Burson RR, Guthmiller KB, López-Roca AL, Lautenschlager KA, McCallin JP 3rd, Hoch MB, Timchenko A, Souza SE, Bryant CE, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH. Neuropsychopharmacology. 2022 Jul. PMID: 35545665.
• Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, Southwick SM, Petrakis IL, Burson RR, Guthmiller KB, López-Roca AL, Lautenschlager KA, McCallin JP 3rd, Hoch MB, Timchenko A, Souza SE, Bryant CE, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH. Neuropsychopharmacology. 2022 Jul; 2022 Jan 19. PMID: 35046508.
• Novel Nicotine Concentration Labels Improve Adolescents' and Young Adults' Understanding of the Nicotine Strength of Electronic Nicotine Delivery System Products.Morean ME, Wackowski OA, Eissenberg T, Delnevo CD, Krishnan-Sarin S, Gueorguieva R. Nicotine Tob Res. 2022 Jun 15. PMID: 35137219.
• Clinical and Financial Outcomes Associated With a Workplace Mental Health Program Before and During the COVID-19 Pandemic.Bondar J, Babich Morrow C, Gueorguieva R, Brown M, Hawrilenko M, Krystal JH, Corlett PR, Chekroud AM. JAMA Netw Open. 2022 Jun 1; 2022 Jun 1. PMID: 35679044.
• Sensitivity, specificity, and tolerability of the BACTrack Skyn compared to other alcohol monitoring approaches among young adults in a field-based setting.Ash GI, Gueorguieva R, Barnett NP, Wang W, Robledo DS, DeMartini KS, Pittman B, Redeker NS, O'Malley SS, Fucito LM. Alcohol Clin Exp Res. 2022 May; 2022 May 14. PMID: 35567595.
• mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression.Averill LA, Averill CL, Gueorguieva R, Fouda S, Sherif M, Ahn KH, Ranganathan M, D'Souza DC, Southwick SM, Sanacora G, Duman RS, Krystal JH, Abdallah CG. J Affect Disord. 2022 Apr 15; 2022 Jan 29. PMID: 35101523.
• Prefrontal Glutamate Neurotransmission in PTSD: A Novel Approach to Estimate Synaptic Strength in Vivo in Humans.Averill LA, Jiang L, Purohit P, Coppoli A, Averill CL, Roscoe J, Kelmendi B, De Feyter HM, de Graaf RA, Gueorguieva R, Sanacora G, Krystal JH, Rothman DL, Mason GF, Abdallah CG. Chronic Stress (Thousand Oaks). 2022 Jan-Dec; 2022 Apr 11. PMID: 35434443.
• Dynamic structural equation modeling of the relationship between alcohol habit and drinking variability.DeMartini KS, Gueorguieva R, Taylor JR, Krishnan-Sarin S, Pearlson G, Krystal JH, O'Malley SS. Drug Alcohol Depend. 2022 Apr 1; 2021 Nov 27. PMID: 35151022.
• Plasma Menthol Glucuronide as a Biomarker for the Behavioral Effects of Menthol and Nicotine in Humans.Gueorguieva R, Schwartz EKC, MacLean RR, DeVito EE, Eid T, Wu R, O'Malley SS, Sofuoglu M. Front Pharmacol. 2022; 2022 Mar 31. PMID: 35431934.
• Corrigendum to: Reducing the Duration of Untreated Psychosis (DUP) in a US Community: A Quasi-Experimental Trial.Srihari VH, Ferrara M, Li F, Kline E, Gülöksüz S, Pollard JM, Cahill JD, Mathis WS, Yoviene Sykes L, Walsh BC, McDermott G, Seidman LJ, Gueorguieva R, Woods SW, Tek C, Keshavan MS. Schizophr Bull Open. 2022 Jan; 2022 Mar 13. PMID: 39144776.
• Longitudinal Trajectories of Multiple Nicotine Product Use Among Youths in the Population Assessment of Tobacco and Health Study.Simon P, Jiang Y, Buta E, Sartor CE, Krishnan-Sarin S, Gueorguieva R. JAMA Netw Open. 2022 Mar 1; 2022 Mar 1. PMID: 35319763.
• Impact of delivery rate on the acute response to intravenous nicotine: A human laboratory study with implications for regulatory science.De Aquino JP, MacLean RR, Gueorguieva R, DeVito EE, Eid T, Sofuoglu M. Addict Biol. 2022 Mar. PMID: 35229960.
• Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory (11) C-UCB-J positron emission tomography study in humans.Angarita GA, Worhunsky PD, Naganawa M, Toyonaga T, Nabulsi NB, Li CR, Esterlis I, Skosnik PD, Radhakrishnan R, Pittman B, Gueorguieva R, Potenza MN, Finnema SJ, Huang Y, Carson RE, Malison RT. Addict Biol. 2022 Mar; 2021 Dec 1. PMID: 34852401.
• Reducing the Duration of Untreated Psychosis (DUP) in a US Community: A Quasi-Experimental Trial.Srihari VH, Ferrara M, Li F, Kline E, Gülöksüz S, Pollard JM, Cahill JD, Mathis WS, Yoviene Sykes L, Walsh BC, McDermott G, Seidman LJ, Gueorguieva R, Woods SW, Tek C, Keshavan MS. Schizophr Bull Open. 2022 Jan; 2022 Jan 4. PMID: 35295656.
• The effects of inhaled flavors on intravenous nicotine.MacLean RR, Gueorguieva R, DeVito EE, Peltier MR, Parida S, Sofuoglu M. Exp Clin Psychopharmacol. 2021 Dec; 2020 May 28. PMID: 32463279.
• Smartband-Based Automatic Smoking Detection and Real-time Mindfulness Intervention: Protocol for a Feasibility Trial.Horvath M, Grutman A, O'Malley SS, Gueorguieva R, Khan N, Brewer JA, Garrison KA. JMIR Res Protoc. 2021 Nov 16; 2021 Nov 16. PMID: 34783663.
• Detecting change in psychiatric functioning in clinical trials for cocaine use disorder: sensitivity of the Addiction Severity Index and Brief Symptom Inventory.Kiluk BD, Roos CR, Aslan M, Gueorguieva R, Nich C, Babuscio TA, Carroll KM. Drug Alcohol Depend. 2021 Nov 1; 2021 Sep 20. PMID: 34600247.
• STRONG STAR and the Consortium to Alleviate PTSD: Shaping the future of combat PTSD and related conditions in military and veteran populations.Peterson AL, Young-McCaughan S, Roache JD, Mintz J, Litz BT, Williamson DE, Resick PA, Foa EB, McGeary DD, Dondanville KA, Taylor DJ, Wachen JS, Fox PT, Bryan CJ, McLean CP, Pruiksma KE, Yarvis JS, Niles BL, Abdallah CG, Averill LA, Back SE, Baker MT, Blount TH, Borah AM, Borah EV, Brock MS, Brown LA, Burg MM, Cigrang JA, DeBeer BB, DeVoe ER, Fina BA, Flanagan JC, Fredman SJ, Gardner CL, Gatchel RR, Goodie JL, Gueorguieva R, Higgs JB, Jacoby VM, Kelly KM, Krystal JH, Lapiz-Bluhm MD, López-Roca AL, Marx BP, Maurer DM, McDevitt-Murphy ME, McGeary CA, Meyer EC, Miles SR, Monson CM, Morilak DA, Moring JC, Mysliwiec V, Nicholson KL, Rauch SAM, Riggs DS, Rosen CS, Rudd MD, Schobitz RP, Schrader CC, Shinn AM, Shiroma PR, Sloan DM, Stern SL, Strong R, Vannoy SD, Young KA, Keane TM. Contemp Clin Trials. 2021 Nov; 2021 Sep 29. PMID: 34600107.
• The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials.Haeny AM, Gueorguieva R, Montgomery L, Bold KW, Fucito LM, Wu R, Muvvala SB, Zweben A, O'Malley SS. Addict Behav. 2021 Nov; 2021 May 1. PMID: 34216871.
• Acute effects of inhaled menthol on cognitive effects of intravenous nicotine among young adult cigarette smokers.Jao NC, Gueorguieva R, Hitsman B, Sofuoglu M. Addict Behav. 2021 Nov; 2021 Jun 18. PMID: 34174551.
• Using an adoption design to test genetically based differences in risk for child behavior problems in response to home environmental influences.Cree RA, Liu C, Gueorguieva R, Neiderhiser JM, Leve LD, Connell CM, Shaw DS, Natsuaki MN, Ganiban JM, Beekman C, Smith MV, Reiss D. Dev Psychopathol. 2021 Oct. PMID: 32654671.
• Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants.Thompson SL, Gianessi CA, O'Malley SS, Cavallo DA, Shi JM, Tetrault JM, DeMartini KS, Gueorguieva R, Pittman B, Krystal JH, Taylor JR, Krishnan-Sarin S. Front Psychiatry. 2021; 2021 Aug 31. PMID: 34531767.
• Association of Vaping and Respiratory Health among Youth in the Population Assessment of Tobacco and Health (PATH) Study Wave 3.Cherian C, Buta E, Simon P, Gueorguieva R, Krishnan-Sarin S. Int J Environ Res Public Health. 2021 Aug 3; 2021 Aug 3. PMID: 34360499.
• Examining depression scores as predictors and moderators of treatment outcomes in patients with binge-eating disorder.Grilo CM, Gueorguieva R, Pittman B. Int J Eat Disord. 2021 Aug; 2021 Jun 17. PMID: 34137474.
• Individual differences in the associations between risk factors for alcohol use disorder and alcohol use-related outcomes.Haeny AM, Gueorguieva R, Jackson A, Morean ME, Krishnan-Sarin S, DeMartini KS, Pearlson GD, Anticevic A, Krystal JH, O'Malley SS. Psychol Addict Behav. 2021 Aug; 2021 Jun 10. PMID: 34110841.
• Threshold dose for intravenous nicotine self-administration in young adult non-dependent smokers.MacLean RR, DeVito EE, Eid T, Parida S, Gueorguieva R, Sofuoglu M. Psychopharmacology (Berl). 2021 Aug; 2021 Apr 1. PMID: 33796907.
• Influence of menthol and green apple e-liquids containing different nicotine concentrations among youth e-cigarette users.Jackson A, Green B, Erythropel HC, Kong G, Cavallo DA, Eid T, Gueorguieva R, Buta E, O'Malley SS, Krishnan-Sarin S. Exp Clin Psychopharmacol. 2021 Aug; 2020 Apr 16. PMID: 32297782.
• Randomized Controlled Trial of Treatments for Loss-of-Control Eating Following Bariatric Surgery.Grilo CM, Ivezaj V, Duffy AJ, Gueorguieva R. Obesity (Silver Spring). 2021 Apr; 2021 Mar 10. PMID: 33694287.
• Mapping data-driven individualized neurobehavioral phenotypes in heavy alcohol drinkers.DeMartini KS, Gueorguieva R, Pearlson G, Krishnan-Sarin S, Anticevic A, Ji LJ, Krystal JH, O'Malley SS. Alcohol Clin Exp Res. 2021 Apr; 2021 Apr 16. PMID: 33605439.
• Sex differences in progestogen- and androgen-derived neurosteroids in vulnerability to alcohol and stress-related disorders.Peltier MR, Verplaetse TL, Mineur YS, Gueorguieva R, Petrakis I, Cosgrove KP, Picciotto MR, McKee SA. Neuropharmacology. 2021 Apr 1; 2021 Feb 16. PMID: 33600842.
• Smoking history and the association between alcohol and e-cigarette use: authors' reply.Roberts W, Verplaetse T, Peltier MKR, Moore KE, Gueorguieva R, McKee SA. Addiction. 2021 Apr; 2020 Dec 29. PMID: 33220148.
• Trends in various e-cigarette devices used by high school adolescents from 2017-2019.Bold KW, Kong G, Morean M, Gueorguieva R, Camenga DR, Simon P, Davis DR, Jackson A, Krishnan-Sarin S. Drug Alcohol Depend. 2021 Feb 1; 2020 Dec 31. PMID: 33421797.
• Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.Grilo CM, Lydecker JA, Morgan PT, Gueorguieva R. Clin Ther. 2021 Jan; 2020 Nov 18. PMID: 33218742.
• Two-part models for repeatedly measured ordinal data with "don't know" category.Gueorguieva R, Buta E, Morean M, Krishnan-Sarin S. Stat Med. 2020 Dec 30; 2020 Sep 9. PMID: 32909252.
• Examining Self-Weighing Behaviors and Associated Features and Treatment Outcomes in Patients with Binge-Eating Disorder and Obesity with and without Food Addiction.Wiedemann AA, Ivezaj V, Gueorguieva R, Potenza MN, Grilo CM. Nutrients. 2020 Dec 23; 2020 Dec 23. PMID: 33374870.
• Randomized Controlled Trial of Behavioral Weight Loss and Stepped Care for Binge-Eating Disorder: 12-Month Follow-up.Grilo CM, White MA, Ivezaj V, Gueorguieva R. Obesity (Silver Spring). 2020 Nov; 2020 Sep 27. PMID: 32985114.
• Data Visualization Tools of Tobacco Product Use Patterns, Transitions and Sex Differences in the PATH Youth Data.Gueorguieva R, Buta E, Simon P, Krishnan-Sarin S, O'Malley SS. Nicotine Tob Res. 2020 Oct 8. PMID: 32219313.
• An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study.Fucito LM, Wu R, O'Malley SS, Hanrahan TH, Ikomi JT, Muvvala S, Carroll KM, Gueorguieva R. J Smok Cessat. 2020 Sep; 2020 Mar 18. PMID: 33312238.
• Prospective association of e-cigarette and cigarette use with alcohol use in two waves of the Population Assessment of Tobacco and Health.Roberts W, Verplaetse T, Peltier MKR, Moore KE, Gueorguieva R, McKee SA. Addiction. 2020 Aug; 2020 Feb 9. PMID: 31977106.
• Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.Hartwell EE, Feinn R, Morris PE, Gelernter J, Krystal J, Arias AJ, Hoffman M, Petrakis I, Gueorguieva R, Schacht JP, Oslin D, Anton RF, Kranzler HR. Addiction. 2020 Aug; 2020 Feb 11. PMID: 31961981.
• Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study.Vicknasingam B, Chooi WT, Rahim AA, Ramachandram D, Singh D, Ramanathan S, Yusof NSM, Zainal H, Murugaiyah V, Gueorguieva R, Mansor SM, Chawarski MC. Yale J Biol Med. 2020 Jun; 2020 Jun 29. PMID: 32607084.
• Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.Abdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M, Sherif M, Ahn KH, D'Souza DC, Formica R, Southwick SM, Duman RS, Sanacora G, Krystal JH. Neuropsychopharmacology. 2020 May; 2020 Feb 24. PMID: 32092760.
• Differential effects of nicotine delivery rate on subjective drug effects, urges to smoke, heart rate and blood pressure in tobacco smokers.Jensen KP, Valentine G, Gueorguieva R, Sofuoglu M. Psychopharmacology (Berl). 2020 May; 2020 Jan 29. PMID: 31996940.
• Modulation of "Protective" Nicotine Perception and Use Profile by Flavorants: Preliminary Findings in E-cigarettes.DeVito EE, Jensen KP, O'Malley SS, Gueorguieva R, Krishnan-Sarin S, Valentine G, Jatlow PI, Sofuoglu M. Nicotine Tob Res. 2020 Apr 21. PMID: 30995302.
• Transitions across tobacco use profiles among adolescents: results from the Population Assessment of Tobacco and Health (PATH) study waves 1 and 2.Simon P, Buta E, Gueorguieva R, Kong G, Morean ME, Camenga DR, Bold KW, Krishnan-Sarin S. Addiction. 2020 Apr; 2020 Feb 5. PMID: 31618491.
• Craving to Quit: A Randomized Controlled Trial of Smartphone App-Based Mindfulness Training for Smoking Cessation.Garrison KA, Pal P, O'Malley SS, Pittman BP, Gueorguieva R, Rojiani R, Scheinost D, Dallery J, Brewer JA. Nicotine Tob Res. 2020 Mar 16. PMID: 29917096.
• Histopathology-guided mass spectrometry differentiates benign nevi from malignant melanoma.Lazova R, Smoot K, Anderson H, Powell MJ, Rosenberg AS, Rongioletti F, Pilloni L, D'Hallewin S, Gueorguieva R, Tantcheva-Poór I, Obadofin O, Camacho C, Hsi A, Kluger HH, Fadare O, Seeley EH. J Cutan Pathol. 2020 Mar; 2019 Nov 27. PMID: 31697431.
• Randomized controlled trial testing the effectiveness of adaptive "SMART" stepped-care treatment for adults with binge-eating disorder comorbid with obesity.Grilo CM, White MA, Masheb RM, Ivezaj V, Morgan PT, Gueorguieva R. Am Psychol. 2020 Feb-Mar. PMID: 32052995.
• The Association of Impulsivity and Family History of Alcohol Use Disorder on Alcohol Use and Consequences.Haeny AM, Gueorguieva R, Morean ME, Krishnan-Sarin S, DeMartini KS, Pearlson GD, Anticevic A, Krystal JH, O'Malley SS. Alcohol Clin Exp Res. 2020 Jan; 2019 Dec 3. PMID: 31693193.
• Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial.Krishnan-Sarin S, O'Malley SS, Franco N, Cavallo DA, Tetrault JM, Shi J, Gueorguieva R, Pittman B, Krystal JH. Neuropsychopharmacology. 2020 Jan; 2019 Oct 7. PMID: 31590179.
• Examining sex as a predictor and moderator of treatment outcomes for binge-eating disorder: Analysis of aggregated randomized controlled trials.Lydecker JA, Gueorguieva R, Masheb R, White MA, Grilo CM. Int J Eat Disord. 2020 Jan; 2019 Sep 9. PMID: 31497876.
• Adolescents' awareness of the nicotine strength and e-cigarette status of JUUL e-cigarettes.Morean ME, Bold KW, Kong G, Gueorguieva R, Camenga DR, Simon P, Jackson A, Cavallo DA, Krishnan-Sarin S. Drug Alcohol Depend. 2019 Nov 1; 2019 Aug 24. PMID: 31487572.
• Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled Trial.Martino S, Zimbrean P, Forray A, Kaufman JS, Desan PH, Olmstead TA, Gilstad-Hayden K, Gueorguieva R, Yonkers KA. J Gen Intern Med. 2019 Nov; 2019 Aug 29. PMID: 31468342.
• Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.Chen MH, Cheng CM, Gueorguieva R, Lin WC, Li CT, Hong CJ, Tu PC, Bai YM, Tsai SJ, Krystal JH, Su TP. Neuropsychopharmacology. 2019 Nov; 2019 Aug 17. PMID: 31421635.
• Targeting neuroinflammation with minocycline in heavy drinkers.Petrakis IL, Ralevski E, Gueorguieva R, Sloan ME, Devine L, Yoon G, Arias AJ, Sofuoglu M. Psychopharmacology (Berl). 2019 Oct; 2019 Mar 27. PMID: 30919006.
• Tobacco use increases risk of food insecurity: An analysis of continuous NHANES data from 1999 to 2014.Mayer M, Gueorguieva R, Ma X, White MA. Prev Med. 2019 Sep; 2019 Jun 29. PMID: 31260724.
• Altered functional connectivity and low-frequency signal fluctuations in early psychosis and genetic high risk.Tang Y, Zhou Q, Chang M, Chekroud A, Gueorguieva R, Jiang X, Zhou Y, He G, Rowland M, Wang D, Fu S, Yin Z, Leng H, Wei S, Xu K, Wang F, Krystal JH, Driesen NR. Schizophr Res. 2019 Aug; 2019 Jan 23. PMID: 30685394.